Results 121 to 130 of about 489,387 (266)

Pædagogikkens placebo

, 2016
Kan man overhovedet stole på uddannelsesforskningen, når den ikke tager højde for den effect, forskeres og læreres entusiasme i forhold til en ny metode kan have for resultaterne?
openaire   +2 more sources

Cytokine Pathways Driving Diverse Tissue Pathologies in Rheumatoid Arthritis

Arthritis &Rheumatology, EarlyView.
Rheumatoid arthritis (RA) is a complex systemic disorder characterized primarily by articular inflammation and destruction with associated functional loss and reduced quality of life. RA is also associated with extra‐articular disease, such as that of the lung, with potentially devastating clinical consequences. The critical importance of comorbidities,
Aurelie Najm, Lyn D. Ferguson, Iain B. McInnes   +2 more
wiley   +1 more source

Once-daily oral ritlecitinib or brepocitinib versus placebo in patients with moderate-to-severely active Crohn's disease (PIZZICATO): an international, randomised, phase 2a trial. [PDF]

EClinicalMedicine
Vermeire S, Allegretti JR, Kim HJ, Long MD, Leszczyszyn J, Schreiber S, Kierkus J, Chandler PD, Ramakrishna J, Peeva E, Vincent MS, Shojaee N, Mahling P, Banfield C, Banerjee A, Gale JD, Hung KE.   +16 more
europepmc   +1 more source

Placebos and Placebo Effects [PDF]

Anaesthesia and Intensive Care, 2010
openaire   +1 more source

A Randomized, Placebo‐Controlled Trial of Hydroxychloroquine in Incomplete Lupus

Arthritis &Rheumatology, EarlyView.
Objective Patients with features of systemic lupus erythematosus (SLE) who do not fulfill classification criteria can be designated as incomplete lupus erythematosus (ILE). This condition includes individuals with a high risk of progression to SLE. Treatment of ILE may reduce symptoms, severity, and incidence of SLE.
Nancy J. Olsen, Duanping Liao, Judith A. James, Joel M. Guthridge, Cristina Arriens, Diane Kamen, Mariko Ishimori, Daniel J. Wallace, Christopher Striebich, Sonali Narain, Benjamin F. Chong, Fan He, Eric W. Schaefer, Vernon M. Chinchilli, David R. Karp   +14 more
wiley   +1 more source

Sjögren Disease—B Cells at the Brink: From Autoimmunity to Lymphomagenesis and the Rise of Novel B Cell–Targeted Therapies

Arthritis &Rheumatology, EarlyView.
Sjögren disease (SjD) is a common systemic autoimmune disorder characterized by inflammation of the exocrine glands, resulting in dryness. Patients frequently exhibit extraglandular manifestations affecting various organ systems. To date, there are no US Food and Drug Administration (FDA)‐approved disease‐modifying therapies for SjD. In this review, we
Rachael A. Gordon, Sara S. McCoy
wiley   +1 more source

Commentary: Working with patients' treatment expectations – what we can learn from homeopathy

Frontiers in Psychology
Simonetta Bernardini, Andrea Dei
doaj   +1 more source

Significance of Participants’ Expectations in Managing the Placebo Effect in Antidepressant Research

Frontiers in Psychiatry, 2019
Marko Curkovic, Marko Curkovic, Andro Kosec, Andro Kosec   +3 more
doaj   +1 more source

The prognostic impact of beta blockers in ischemic heart failure: time for a paradigm shift? [PDF]

Heart Fail Rev
Castiello DS, Calvelli P, Anniballo A, Romano LR, Polimeni A, Curcio A.   +5 more
europepmc   +1 more source

Sobre placebo e efeito placebo [PDF]

Revista Latinoamericana de Psicopatologia Fundamental, 2002
Erney Plessmann de Camargo, Mônica Teixeira   +1 more
openaire   +2 more sources